These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11291803)

  • 1. Acute and long-term effects of atrioventricular junction ablation and VVIR pacemaker in symptomatic patients with chronic lone atrial fibrillation and normal ventricular response.
    Ueng KC; Tsai TP; Tsai CF; Wu DJ; Lin CS; Lee SH; Chen SA
    J Cardiovasc Electrophysiol; 2001 Mar; 12(3):303-9. PubMed ID: 11291803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.
    Kay GN; Ellenbogen KA; Giudici M; Redfield MM; Jenkins LS; Mianulli M; Wilkoff B
    J Interv Card Electrophysiol; 1998 Jun; 2(2):121-35. PubMed ID: 9870004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias.
    Manolis AG; Katsivas AG; Lazaris EE; Vassilopoulos CV; Louvros NE
    J Interv Card Electrophysiol; 1998 Mar; 2(1):71-6. PubMed ID: 9869999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    Schütte F; Lüdorff G; Grove R; Kranig W; Thale J
    Cardiol J; 2009; 16(3):246-9. PubMed ID: 19437399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation: effect on quality of life and exercise performance.
    Natale A; Zimerman L; Tomassoni G; Newby K; Leonelli F; Fanelli R; Beheiry S; Pisano E
    Pacing Clin Electrophysiol; 1999 Nov; 22(11):1634-9. PubMed ID: 10598967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation.
    Tan ES; Rienstra M; Wiesfeld AC; Schoonderwoerd BA; Hobbel HH; Van Gelder IC
    Europace; 2008 Apr; 10(4):412-8. PubMed ID: 18272509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The influence of radiofrequency (RF) ablation of the atrioventricular junction in atrial fibrillation on left ventricular systolic function, exercise tolerance and quality of life].
    Lelakowski J; Majewski J; Bigaj J; Szczepkowski J; Dreher A; Bednarek J
    Przegl Lek; 2009; 66(5):222-7. PubMed ID: 19739578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deterioration of left ventricular function following atrio-ventricular node ablation and right ventricular apical pacing in patients with permanent atrial fibrillation.
    Szili-Torok T; Kimman GP; Theuns D; Poldermans D; Roelandt JR; Jordaens LJ
    Europace; 2002 Jan; 4(1):61-5. PubMed ID: 11858154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Left ventricular systolic function, paced QT dispersion, exercise tolerance and quality of life in long term follow up after ventricular pacemaker implantation (VVIR) and radiofrequency atrioventricular junction ablation in drug refractory atrial fibrillation].
    Lelakowski J; Małecka B; Bednarek J; Bigaj J
    Pol Merkur Lekarski; 2008 Mar; 24(141):190-4. PubMed ID: 18634282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular mechanics during right ventricular apical or left ventricular-based pacing in patients with chronic atrial fibrillation after atrioventricular junction ablation.
    Simantirakis EN; Vardakis KE; Kochiadakis GE; Manios EG; Igoumenidis NE; Brignole M; Vardas PE
    J Am Coll Cardiol; 2004 Mar; 43(6):1013-8. PubMed ID: 15028360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation of atrioventricular junction and pacemaker implantation versus modulation of atrioventricular conduction in drug refractory atrial fibrillation.
    Proclemer A; Della Bella P; Tondo C; Facchin D; Carbucicchio C; Riva S; Fioretti P
    Am J Cardiol; 1999 May; 83(10):1437-42. PubMed ID: 10335758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials.
    Bradley DJ; Shen WK
    Heart Rhythm; 2007 Feb; 4(2):224-32. PubMed ID: 17275763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modulation of atrioventricular conduction in patients with atrial fibrillation or flutter. Immediate and long-term results].
    Carbucicchio C; Lavarra F; Riva S; Fassini G; Della Bella P
    Cardiologia; 1995 Dec; 40(12):927-40. PubMed ID: 8901043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fixed-rate vs. rate-RESPONSIve pacing on exercise capacity in patients with permanent, refractory atrial fibrillation and left ventricular dysfunction treated with atrioventricular junction aBLation and bivEntricular pacing (RESPONSIBLE): a prospective, multicentre, randomized, single-blind study.
    Palmisano P; Aspromonte V; Ammendola E; Dell'era G; Ziacchi M; Guerra F; Aquilani S; Maglia G; Del Giorno G; Giubertoni A; Boriani G; Capucci A; Pietro Ricci R; Accogli M;
    Europace; 2017 Mar; 19(3):414-420. PubMed ID: 26941340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation.
    Twidale N; McDonald T; Nave K; Seal A
    Pacing Clin Electrophysiol; 1998 Apr; 21(4 Pt 1):641-51. PubMed ID: 9584293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrio-ventricular junction ablation and pacemaker treatment: a comparison between men and women.
    Carnlöf C; Insulander P; Jensen-Urstad M; Iwarzon M; Gadler F
    Scand Cardiovasc J; 2018 Jun; 52(3):120-126. PubMed ID: 29537317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias.
    Twidale N; Sutton K; Bartlett L; Dooley A; Winstanley S; Heddle W; Hassam R; Koutsounis H
    Pacing Clin Electrophysiol; 1993 Jun; 16(6):1275-84. PubMed ID: 7686657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of patients treated by radiofrequency ablation of the atrioventricular junction.
    Jensen SM; Bergfeldt L; Rosenqvist M
    Pacing Clin Electrophysiol; 1995 Sep; 18(9 Pt 1):1609-14. PubMed ID: 7491304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study).
    Doshi RN; Daoud EG; Fellows C; Turk K; Duran A; Hamdan MH; Pires LA;
    J Cardiovasc Electrophysiol; 2005 Nov; 16(11):1160-5. PubMed ID: 16302897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.